BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22879065)

  • 21. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
    Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
    J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells.
    Czajkowski R; Barańska J
    Acta Biochim Pol; 2002; 49(4):877-89. PubMed ID: 12545194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous GAB
    Blanchart A; Fernando R; Häring M; Assaife-Lopes N; Romanov RA; Andäng M; Harkany T; Ernfors P
    Oncogene; 2017 Feb; 36(6):777-786. PubMed ID: 27375015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium signaling in glioma cells--the role of nucleotide receptors.
    Wypych D; Pomorski P
    Adv Exp Med Biol; 2013; 986():61-79. PubMed ID: 22879064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
    Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
    Exp Cell Res; 2011 Oct; 317(16):2321-32. PubMed ID: 21749867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of macrophage inflammatory protein-1α and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X₇ receptor.
    Fang KM; Wang YL; Huang MC; Sun SH; Cheng H; Tzeng SF
    J Neurosci Res; 2011 Feb; 89(2):199-211. PubMed ID: 21162127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gab2 expression in glioma and its implications for tumor invasion.
    Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
    Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth.
    Tang H; Liu X; Wang Z; She X; Zeng X; Deng M; Liao Q; Guo X; Wang R; Li X; Zeng F; Wu M; Li G
    Brain Res; 2011 May; 1390():21-32. PubMed ID: 21435336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of Akt2 inhibits migration and invasion of glioma cells.
    Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
    Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of TIP30 inhibits the growth and invasion of glioma cells.
    Hu Y; Chen F; Liu F; Liu X; Huang N; Cai X; Sun Y; Li A; Luo R
    Mol Med Rep; 2016 Jan; 13(1):605-12. PubMed ID: 26718891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular purines, purinergic receptors and tumor growth.
    Di Virgilio F; Adinolfi E
    Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic signaling in atherosclerosis.
    Ferrari D; Vitiello L; Idzko M; la Sala A
    Trends Mol Med; 2015 Mar; 21(3):184-92. PubMed ID: 25637413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine Signaling in Glioma Cells.
    Ceruti S; Abbracchio MP
    Adv Exp Med Biol; 2020; 1202():13-33. PubMed ID: 32034707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview.
    Bergamin LS; Braganhol E; Zanin RF; Edelweiss MI; Battastini AM
    J Biomed Biotechnol; 2012; 2012():959848. PubMed ID: 23118517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.